Etubics Corporation has received a $1.03 million grant from the National Institutes of Health (NIH) to move a vaccine for human papilloma virus (HPV) developed by a Sanford researcher to clinical trials. The vaccine was engineered by Sanford Research's John Lee and his team in collaboration with Etubics. Dr. John Lee discusses the vaccine.
Vaccine For HPV Virus Being Tested In Clinical Trials
Facebook Twitter LinkedIn Email
Your browser doesn’t support HTML5 audio